Bank of New York Mellon Corp
BankPosition in DSGN — Design Therapeutics, Inc.
CIK 1390777
NEW YORK, NY
Position in DSGN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$847,421
+$50,357 QoQ
Shares Held
79,645
-6.3% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bank of New York Mellon Corp holds $4,203,725,512 across 270 Biotechnology names. DSGN ranks #182 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,586,427 | $708,403,098 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
765,411 | $591,387,145 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,679,371 | $317,485,079 | |
| 4 | INSM |
INSMED Inc
|
1,262,749 | $206,484,708 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
491,200 | $162,523,337 | |
| 6 | INCY |
Incyte Corp
|
989,709 | $93,151,403 | |
| 7 | TECH |
BIO-TECHNE Corp
|
1,759,119 | $91,931,549 | |
| 8 | MRNA |
Moderna, Inc.
|
1,691,205 | $85,913,207 |
All Filings in DSGN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $847,421 | 79,645 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $797,064 | 84,975 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $658,685 | 87,475 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $318,811 | 94,603 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $368,042 | 95,348 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $588,296 | 95,348 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $533,291 | 99,125 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $395,668 | 118,110 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $464,424 | 115,242 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $320,098 | 120,792 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $285,068 | 120,792 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $772,788 | 122,665 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $715,783 | 124,053 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,297,725 | 126,484 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,093,459 | 125,207 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,433,376 | 102,384 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,452,788 | 89,956 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $1,436,781 | 67,108 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $535,831 | 36,476 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $666,254 | 33,497 | Shares | Defined | 2021-08-11 | |
| No filing history on record for this holder in this stock. | ||||||